CENTRO DE INGENIER A GENETICA Y BIOTECNOLOG A

Patent Applications and Registrations

Patent applications and USPTO patent grants for CENTRO DE INGENIER A GENETICA Y BIOTECNOLOG A.The latest application filed is for "vaccine composition comprising a mutant of human interleukin-15".

Company Profile

1.3.11

CENTRO DE INGENIER A GENETICA Y BIOTECNOLOG A - La Habana CU
CENTRO DE INGENIER A GENETICA Y BIOTECNOLOG A - Playa, Ciudad de La Habana CU
CENTRO DE INGENIER A GENETICA Y BIOTECNOLOG A - Playa La Habana CU
Centro De Ingeniería Genetica Y Biotecnología - Havana CU
CENTRO DE INGENIER A GENETICA Y BIOTECNOLOG A - Playa la Habana N/A CU
CENTRO DE INGENIER A GENETICA Y BIOTECNOLOG A - Cubanacan, Playa CU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vaccine Composition Comprising A Mutant Of Human Interleukin-15 App 20220259300 - RODRIGUEZ ALVAREZ; Yunier ; et al.	2022-08-18
Pharmaceutical Composition That Includes The Surface And Nucleocapsid Antigens Of The Hepatitis B Virus App 20220193228 - AGUILAR RUBIDO; Julio Cesar ; et al.	2022-06-23
Pharmaceutical Combination Comprising Epidermal Growth Factor and Secretagogue Peptide GHRP6 for the Restoration of Brain Damage App 20210196793 - GARCIA DEL BARCO HERRERA; Diana ; et al.	2021-07-01
Hepatitis B Vaccine Transnasal Administration System App 20210187101 - KAMISHITA; Taizou ; et al.	2021-06-24
Pharmaceutical Composition That Includes The Surface And Nucleocapsid Antigens Of The Hepatitis B Virus App 20200297840 - AGUILAR RUBIDO; Julio Cesar ; et al.	2020-09-24
Feet positioning system for magnetic resonance imaging studies Grant 10,765,341 - Cabal Mirabal , et al. Sep	2020-09-08
Vaccine Composition Comprising A Mutant Of Human Interleukin-15 App 20200181254 - RODRIGUEZ ALVAREZ; Yunier ; et al.	2020-06-11
Method for inhibiting HIV replication in mammal and human cells Grant 10434137 -	2019-10-08
Beta hairpin peptides having antiviral properties against Dengue virus Grant 9,896,482 - Chinea Santiago , et al. February 20, 2	2018-02-20
Vesicles comprising epidermal growth factor and compositions thereof Grant 9,717,776 - Santana Milian , et al. August 1, 2	2017-08-01
Beta Hairpin Peptides Having Antiviral Properties Against Dengue Virus App 20170152290 - CHINEA SANTIAGO; Glay ; et al.	2017-06-01
Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases App 20140356319 - Penton Rol; Giselle ; et al.	2014-12-04
Cancer Therapy Method App 20140206621 - Guerra Vallespi; Maribel ; et al.	2014-07-24
Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses App 20090312190 - Chinea Santiago; Glay ; et al.	2009-12-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.